Remove 2017 Remove FDA Remove Governance
article thumbnail

Public Health Product Hops

Bill of Health

Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. Could Congress or the FDA have incentivized the manufacturer to initiate the switch much sooner?

article thumbnail

EU and US Regulatory Challenges Facing AI Health Care Innovator Firms

Bill of Health

Beyond the health care sector-specific Medical Devices Regulation (EU) 2017/745 (MDR) and the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR), this mix of AI & Data related regulatory requirements stems from a series of generalized, cross-sectoral EU laws of the last 5 years. The sectorialism of the U.S.

FDA 289
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI roundup: HEALWELL AI buys LLMs, Forward to roll out staffless health kiosks

Healthcare It News

Companies are expanding their reach with artificial intelligence through acquisitions, investments and government approvals on a near-daily basis. " FDA clears Lunit breast cancer screening algorithm Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, announced Tuesday that the U.S.

FDA 242
article thumbnail

AI’s Ability to Manipulate Decision Making Requires a Moratorium on Its Use in Obtaining Consent for Biomedical Research

Bill of Health

The federal government’s commitment to assuring that participants in human subject research provide fully informed consent dates back to the U.S In 2017, Congress acted again to update the Common Rule and strengthen the provisions related to consent. While the U.S.

article thumbnail

Cybersecurity Vulnerabilities in Implantable Medical Devices

HIT Consultant

Food and Drug Administration (FDA). In 2017, the regulator warned the radio-frequency-enabled devices manufactured by St. However, as of 2023, the FDA orders they meet specific security guidelines — patches must be available periodically and in emergencies, and manufacturers must submit a software bill of materials.

FDA 115
article thumbnail

Biotech Startup Obatala Sciences Raises $3M for Organ-on-a-Chip for Research

HIT Consultant

These solutions, provided to pharmaceutical companies, government labs, and researchers, are designed to accelerate the study and prevention of diseases in the fields of obesity, diabetes, cancer, and regenerative medicines. Funding Accelerates Commercialisation of Research-Enabling Solutions.

FDA 98
article thumbnail

Health Privacy and Our Ambivalent Tech-Embrace – Lessons for Digital Health Innovators

Health Populi

Even so, 2 in 3 adults said they would likely get an app to track a medical condition that was approved by the FDA. The phrase “concerned embrace” was coined in a 2017 Deloitte consumer study on mobile technology trends. FDA clearance makes a difference in peoples’ trust with health apps, with 2 in 3 U.S.